Effect of Caffeine on Fetal Growth

This study has been completed.

Sponsored by:	The Danish Epdiemiology Science Centre
Information provided by:	The Danish Epdiemiology Science Centre
ClinicalTrials.gov Identifier:	NCT00131690

Purpose

The purpose of this study is to determine whether caffeine has any effect on birth weight.

Condition	Intervention	Phase
Birth Weight	Drug: Nescafé Gold Blend (exposed) Drug: Nescafé Decaffeinated (controls)	Phase IV

MedlinePlus related topics: Caffeine

Study Type:	Interventional
Study Design:	Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Official Title:	The Importance of Caffeine in Fetal Growth

Further study details as provided by The Danish Epdiemiology Science Centre:

Primary Outcome Measures:

Estimated Enrollment:	1200
Study Start Date:	April 1996
Estimated Study Completion Date:	August 2002

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00131690

Locations

Denmark, Aarhus
Danish Epidemiology Science Centre
Vennelyst Boulevard 6, Aarhus, Denmark, 8000

Sponsors and Collaborators

The Danish Epdiemiology Science Centre

Investigators

Study Chair:

Jørn Olsen, Professor

Danish Epidemiology Science Centre

More Information

Publications indexed to this study:

Study ID Numbers:	1994/2974
Study First Received:	August 17, 2005
Last Updated:	October 7, 2005
ClinicalTrials.gov Identifier:	NCT00131690
Health Authority:	Denmark: The Regional Committee on Biomedical Research Ethics

Keywords provided by The Danish Epdiemiology Science Centre:

Caffeine
Coffee
Randomized
Birth weight

Study placed in the following topic categories:

Caffeine citrate
Body Weight
Birth Weight
Signs and Symptoms
Caffeine

Additional relevant MeSH terms:

Phosphodiesterase Inhibitors
Molecular Mechanisms of Pharmacological Action
Therapeutic Uses
Physiological Effects of Drugs

Central Nervous System Stimulants
Enzyme Inhibitors
Central Nervous System Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009